A Multicenter, Open-Label, First-in-human Study of TYRA-200 in Advanced Intrahepatic Cholangiocarcinoma and Other Solid Tumors with Activating FGFR2 Gene Alterations (SURF201).

Jordi Rodon Ahnert,Sameek Roychowdhury,Haley Ellis, Fernando F. Blanco,Timothy Burn, Jennifer Michelle Davis, Alex Balcer, Alena Zalutskaya,Robin Kate Kelley

Journal of Clinical Oncology（2025）

Cited 0|Views2

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined